Alcon to acquire STAAR Surgical for $1.5 billion

Alcon agreed to acquire all outstanding shares of STAAR Surgical for $28 per share in cash, valuing STAAR at approximately $1.5 billion in equity value. STAAR is a leader in refractive surgery using Implantable Collamer Lenses.

“The acquisition of STAAR enhances our ability to offer a leading surgical vision correction solution for those who are not ideal candidates for other refractive surgeries such as LASIK.”investors.staar.com

• 1 source
• investors.staar.comAlcon Agrees to Acquire STAAR Surgical – STAAR SurgicalAug 5, 2025

Summarized from public sources; check the original articles before acting on it.